Intensive exercise program after spinal cord injury (" Full-On"): Study protocol for a randomized controlled trial

M.P. Galea, Sarah Dunlop, G.M. Davis, A. Nunn, T. Geraghty, Y. Hsueh, L. Churilov

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    Abstract

    Background: Rehabilitation after spinal cord injury (SCI) has traditionally involved teaching compensatory strategies for identified impairments and deficits in order to improve functional independence. There is some evidence that regular and intensive activity-based therapies, directed at activation of the paralyzed extremities, promotes neurological improvement. The aim of this study is to compare the effects of a 12-week intensive activity-based therapy program for the whole body with a program of upper body exercise.Methods/Design: A multicenter, parallel group, assessor-blinded randomized controlled trial will be conducted. One hundred eighty-eight participants with spinal cord injury, who have completed their primary rehabilitation at least 6 months prior, will be recruited from five SCI units in Australia and New Zealand. Participants will be randomized to an experimental or control group. Experimental participants will receive a 12-week program of intensive exercise for the whole body, including locomotor training, trunk exercises and functional electrical stimulation-assisted cycling. Control participants will receive a 12-week intensive upper body exercise program. The primary outcome is the American Spinal Injuries Association (ASIA) Motor Score. Secondary outcomes include measurements of sensation, function, pain, psychological measures, quality of life and cost effectiveness. All outcomes will be measured at baseline, 12 weeks, 6 months and 12 months by blinded assessors. Recruitment commenced in January 2011.Discussion: The results of this trial will determine the effectiveness of a 12-week program of intensive exercise for the whole body in improving neurological recovery after spinal cord injury. Trial registration: NCT01236976 (10 November 2010), ACTRN12610000498099 (17 June 2010). © 2013 Galea et al.; licensee BioMed Central Ltd.
    Original languageEnglish
    Pages (from-to)9pp
    JournalTrials
    Volume14
    Issue number1
    DOIs
    Publication statusPublished - 2013

      Fingerprint

    Cite this